These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33791884)

  • 21. Breast Arterial Calcification: A Potential Biomarker for Atherosclerotic Cardiovascular Disease Risk?
    Yoon YE; Yun B; Kim KM; Suh JW
    Curr Atheroscler Rep; 2021 Mar; 23(5):21. PubMed ID: 33772359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-first recall of healthy individuals by polygenic risk score reveals differences in coronary artery calcium.
    Forrest IS; Chan L; Chaudhary K; Saha A; Wen HH; Cepin CL; Marquez-Luna C; Rocheleau G; Cho J; Narula J; Nadkarni GN; Do R
    Am Heart J; 2022 Aug; 250():29-33. PubMed ID: 35526571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction.
    Nurmohamed NS; Kraaijenhof JM; Mayr M; Nicholls SJ; Koenig W; Catapano AL; Stroes ESG
    Eur Heart J; 2023 May; 44(18):1594-1607. PubMed ID: 36988179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the Performance of the RECODe Equation with the Addition of Polygenic Risk Scores for Adverse Cardiovascular Outcomes in Individuals with Type II Diabetes.
    Tsao NL; Judy R; Levin MG; Shakt G; ; ; Voight BF; Chen J; Damrauer SM
    medRxiv; 2023 May; ():. PubMed ID: 37205500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Progress in cardiovascular prevention: from risk charts to polygenic risk score and precision prevention].
    Boccanelli A; Bottà G; Vanuzzo D
    G Ital Cardiol (Rome); 2021 Aug; 22(8):599-605. PubMed ID: 34310561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement.
    Wong ND; Budoff MJ; Ferdinand K; Graham IM; Michos ED; Reddy T; Shapiro MD; Toth PP
    Am J Prev Cardiol; 2022 Jun; 10():100335. PubMed ID: 35342890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment.
    Miname MH; Bittencourt MS; Nasir K; Santos RD
    Curr Opin Lipidol; 2019 Apr; 30(2):82-87. PubMed ID: 30649025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimizing Dyslipidemia Management for the Prevention of Cardiovascular Disease: a Focus on Risk Assessment and Therapeutic Options.
    Berman AN; Blankstein R
    Curr Cardiol Rep; 2019 Aug; 21(9):110. PubMed ID: 31378838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic Predisposition of Atherosclerotic Cardiovascular Disease in Ancient Human Remains.
    Wurst C; Maixner F; Paladin A; Mussauer A; Valverde G; Narula J; Thompson R; Zink A
    Ann Glob Health; 2024; 90(1):6. PubMed ID: 38273870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polygenic Risk Scores to Identify CVD Risk and Tailor Therapy: Hope or Hype?
    German CA; Shapiro MD
    Curr Atheroscler Rep; 2021 Jun; 23(9):47. PubMed ID: 34181090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using Polygenic Risk Scores for Prioritizing Individuals at Greatest Need of a Cardiovascular Disease Risk Assessment.
    Chung R; Xu Z; Arnold M; Ip S; Harrison H; Barrett J; Pennells L; Kim LG; Di Angelantonio E; Paige E; Ritchie SC; Inouye M; Usher-Smith JA; Wood AM
    J Am Heart Assoc; 2023 Aug; 12(15):e029296. PubMed ID: 37489768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of the Pooled Cohort atherosclerotic cardiovascular disease risk score in hepatitis C virus-infected persons.
    Chew KW; Bhattacharya D; Horwich TB; Yan P; McGinnis KA; Tseng C; Freiberg MS; Currier JS; Butt AA
    J Viral Hepat; 2017 Oct; 24(10):814-822. PubMed ID: 28273386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polygenic Scores to Assess Atherosclerotic Cardiovascular Disease Risk: Clinical Perspectives and Basic Implications.
    Aragam KG; Natarajan P
    Circ Res; 2020 Apr; 126(9):1159-1177. PubMed ID: 32324503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults: An Analysis of Pooled Population-Based Studies.
    Yano Y; O'Donnell CJ; Kuller L; Kavousi M; Erbel R; Ning H; D'Agostino R; Newman AB; Nasir K; Hofman A; Lehmann N; Dhana K; Blankstein R; Hoffmann U; Möhlenkamp S; Massaro JM; Mahabadi AA; Lima JAC; Ikram MA; Jöckel KH; Franco OH; Liu K; Lloyd-Jones D; Greenland P
    JAMA Cardiol; 2017 Sep; 2(9):986-994. PubMed ID: 28746709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia.
    Trinder M; Li X; DeCastro ML; Cermakova L; Sadananda S; Jackson LM; Azizi H; Mancini GBJ; Francis GA; Frohlich J; Brunham LR
    J Am Coll Cardiol; 2019 Jul; 74(4):512-522. PubMed ID: 31345425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Wilson PWF; Polonsky TS; Miedema MD; Khera A; Kosinski AS; Kuvin JT
    Circulation; 2019 Jun; 139(25):e1144-e1161. PubMed ID: 30586775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Three Atherosclerotic Cardiovascular Disease Risk Scores With and Without Coronary Calcium for Predicting Revascularization and Major Adverse Coronary Events in Symptomatic Patients Undergoing Positron Emission Tomography-Stress Testing.
    Anderson JL; Le VT; Min DB; Biswas S; Minder CM; McCubrey RO; Knight S; Horne BD; Mason S; Lappe DL; Muhlestein JB; Knowlton KU
    Am J Cardiol; 2020 Feb; 125(3):341-348. PubMed ID: 31806210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events.
    D'Erasmo L; Minicocci I; Di Costanzo A; Pigna G; Commodari D; Ceci F; Montali A; Brancato F; Stanca I; Nicolucci A; Ascione A; Galea N; Carbone I; Francone M; Maranghi M; Arca M
    J Am Heart Assoc; 2021 May; 10(9):e018932. PubMed ID: 33890476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refining ASCVD risk prediction and temporal trends: the role of chronic kidney disease, polygenic risk scores, and longitudinal studies.
    Gawash A; Zia H; Lo DF
    Eur J Prev Cardiol; 2023 May; 30(7):e39-e40. PubMed ID: 36651478
    [No Abstract]   [Full Text] [Related]  

  • 40. Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition.
    Rosenblit PD
    Curr Diab Rep; 2019 Jul; 19(8):61. PubMed ID: 31332544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.